Home healthcare company DispatchHealth has raised $330 million in a funding round led by Optum Ventures, Home Health Care News reported Nov. 15.
Category: ROOT
Mount Sinai names dean of women’s health
New York City-based Mount Sinai has appointed Michal Elovitz, MD, to serve as dean for women’s health research at the Icahn School of Medicine, effective March 1. She will also serve as director of the center for the advancement of female biology, acco…
Health systems race to tap women’s health market
Major health systems are setting their sights on the women’s health market and opening specialized centers just for female patients, NC Health News reported Nov. 14.
Lifepoint Health’s health tech incubator launches 6 new companies
Lifepoint Health’s joint startup incubator for health tech, 25m Health, has launched six new companies and funded five others since its launch in November 2021.
Top-ranked hospitals for 10 specialties
Minnesota’s Mayo Clinic Rochester has been ranked as the top hospital across five specialties in 2023 by Newsweek, more than any other hospital.
Google, Highmark and League to collaborate on digital health platform
Google Cloud, health insurance company Highmark Health and healthcare software company League are forming a new digital health platform for Highmark Health’s members.
Florida ASC trends: 4 new developments
From a Stryker partnership to a new spine ASC, here are four ASC moves in Florida Becker’s has reported on since Sept 14.
Iowa hospital breaks ground on multimillion-dollar renovation project
Carroll, Iowa-based St. Anthony Regional Hospital has begun construction on multimillion-dollar renovations for its birthing center, the Carroll Times Herald reported Nov. 15.
California hospital taps Dr. Carlos Becerra for medical director
Newport Beach, Calif.-based Hoag Memorial Hospital Presbyterian tapped Carlos Becerra, MD, as medical director of cancer research for its Hoag Family Cancer Institute.
5 months after FDA clearance, CVS allows pharmacists to prescribe Paxlovid
CVS began allowing its pharmacists to prescribe Pfizer’s COVID-19 antiviral treatment Nov. 15, more than five months after the FDA authorized the workforce to prescribe it, and debate has ensued.
